Submitted by Anonymous (not verified) on 6 October 2025 - 15:20
Human medicines European public assessment report (EPAR): Imlygic, talimogene laherparepvec, Date of authorisation: 16/12/2015, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imlygic, talimogene laherparepvec, Date of authorisation: 16/12/2015, Revision: 16, Status: Authorised